Anzeige
Mehr »
Login
Montag, 16.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Revolution im Wasserstoffmarkt: Diese Aktie könnte der nächste Überflieger sein!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
578 Leser
Artikel bewerten:
(2)

Royal Philips: Philips and TriHealth announce multi-year partnership at heart of new TriHealth Heart & Vascular Institute on the campus of Bethesda North Hospital

Finanznachrichten News

February 9, 2023

With access to innovative healthcare technologies, clinicians can continue to provide exceptional care to local and surrounding communities and deliver on Quadruple Aim

Amsterdam, the Netherlands and Cincinnati, Ohio, USA -Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long-term strategic partnership with TriHealth, a leading Cincinnati-based integrated healthcare delivery system, to adopt Philips' integrated portfolio of cardiology solutions for its new TriHealth Heart & Vascular Institute on the campus of Bethesda North Hospital and the Harold and Eugenia Thomas Comprehensive Care Center. The agreement allows TriHealth to expand cardiac care and deliver on its promise to the community: provide high quality care, act for the benefit of the community, cooperate with the physicians and other providers to coordinate health services, and to educate the next generation of healthcare providers.

TriHealth is a full-service, not-for-profit health system that services three Ohio counties as well as Kentucky residents living close to the state border, with a wide range of clinical, educational, preventive and social programs. As one of the top integrated health systems in greater Cincinnati, TriHealth is committed to providing access to the highest quality medical services for the communities it serves. Over the last few years, TriHealth has made significant investments, including its recent affiliation with the Cleveland Clinic Heart, Vascular & Thoracic Institute, to establish itself as the region's destination heart and vascular program. Partnering with Philips is the latest in TriHealth enterprise collaborations focused on sharing best practices and developing new treatments and therapies to achieve the best possible outcomes for heart patients across the region.

"Our mission at TriHealth is to improve the health status of the people we serve. The reimagined spaces and workflow in the new Heart & Vascular Institute will enable us to meet our clinical and operational goals, while the new business model will allow us to adopt the technologies that we need, when we need them," said Jamie Easterling, president and COO of Bethesda North Hospital. "We see tremendous value in our partnership with Philips. Its industry-leading technology, design services, training, ongoing education and support provide all the tools for us to deliver unmatched patient care."

The TriHealth Heart & Vascular Institute is comprised of nine interventional suites where patients can be diagnosed and treated with a range of minimally-invasive cardiovascular procedures. The rooms are equipped with Philips image-guided therapy solutions, including Azurion, and Philips cardiovascular ultrasound systems Affiniti and EPIQ, for improved imaging, simplified navigation, more efficient AI-enhanced workflows and shorter procedure times. The co-location of the labs allows for easy collaboration with specialists, who are only steps away, for consultation during procedures and interventions. For example, an electrophysiologist can easily be pulled into a procedure for a pacemaker implant. In situations like this, standardizing on Philips technology provides consistency across the labs and ensures physicians have familiarity with the system regardless of the lab in which they are working.

"TriHealth understands that it takes both technology and true partnership to deliver the innovation needed to address today's healthcare challenges," said Jeff DiLullo, chief market leader, Philips North America. "Through this collaboration, Bethesda North is becoming the region's premier destination for heart and vascular care, giving clinicians access to the best technology available so they can provide their patients the quality care they need, and do so closer to home."

Later this year, TriHealth will open a new reception/waiting area, nursing stations and pre/post operative bays. Patients and staff can expect additional technologies such as patient monitoring, including advanced clinical decision support tools and smart alarms, which can help clinicians intervene before patients have an adverse event, and Philips ultra-mobile Lumify handheld ultrasound, the company's tablet-based ultrasound that provides telehealth capabilities. The partnership also consists of technology management plans, helping to ensure the health system can benefit from the latest technology innovations which will help them drive their strategy and deliver on their mission.

For further information, please contact:

Mark Groves
Philips Global Press Office
Tel: +31 631 639 916
Email: mark.groves@philips.com

Avi Dines
Philips North America
Tel: + 1 781 690 3814
Email: avi.dines@philips.com

Tom Lange
TriHealth
Senior Public Relations Consultant
Tel: + 1 513 569 6728
Email: Thomas_lange@trihealth.com

About Royal Philips
Royal Philips.

About TriHealth
TriHealth is hospitals, physicians and the community working together to help people live better. We provide clinical, educational, preventive and social programs through Bethesda North, Bethesda Butler, Good Samaritan and McCullough-Hyde hospitals and more than 140 other locations throughout Greater Cincinnati. This includes an ambulatory network, physician practices, research division, employer-based health services, hospice care, and fitness and health facilities. Learn more at TriHealth.com, Facebook.com/TriHealth, @TriHealth on Twitter, and at YouTube.com/TriHealth.

Attachments

  • Cardiac interventional suite at TriHealth Heart & Vascular Institute on the campus at Bethesda North (https://ml-eu.globenewswire.com/Resource/Download/650938ab-b134-4429-a698-c214096bb247)
  • Exam room in the cardiac interventional suite at TriHealth Heart & Vascular Institute on the campus of Bethesda North (https://ml-eu.globenewswire.com/Resource/Download/4eeb793e-e235-4c16-a2da-e19962a792a7)
  • Control room in the cardiac interventional suite at TriHealth Heart & Vascular Institute on the campus of Bethesda North (https://ml-eu.globenewswire.com/Resource/Download/0a3ee22c-b493-46c5-91ad-630f6c181bde)

© 2023 GlobeNewswire (Europe)
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.